FUSOGENIC-OLIGOARGININE PEPTIDE-MEDIATED DELIVERY OF siRNAs TARGETING THE CIP2A ONCOGENE IN VIVO

被引：0
|
作者：
Dumitriu, Anca [1 ]
Attaway, Christopher [1 ]
Jakymiw, Andrew [1 ]
机构：
[1] MUSC, Charleston, SC USA
来源：
PEDIATRIC BLOOD & CANCER | 2014年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S35 / S35
页数：1
相关论文
共 38 条
  • [1] Fusogenic-Oligoarginine Peptide-Mediated Delivery of siRNAs Targeting the CIP2A Oncogene into Oral Cancer Cells
    Cantini, Liliana
    Attaway, Christopher C.
    Butler, Betsy
    Andino, Lourdes M.
    Sokolosky, Melissa L.
    Jakymiw, Andrew
    PLOS ONE, 2013, 8 (09):
  • [2] Fusogenic-oligoarginine peptide-mediated silencing of the CIP2A oncogene suppresses oral cancer tumor growth in vivo
    Alexander-Bryant, Angela A.
    Dumitriu, Anca
    Attaway, Christopher C.
    Yu, Hong
    Jakymiw, Andrew
    JOURNAL OF CONTROLLED RELEASE, 2015, 218 : 72 - 81
  • [3] Fusogenic-oligoarginine peptide-mediated silencing of the CIP2A oncogene suppresses oral cancer tumor growth in vivo
    Alexander-Bryant, Angela
    Dumitriu, Anca
    Attaway, Christopher
    Yu, Hong
    Jakymiw, Andrew
    CANCER RESEARCH, 2015, 75
  • [4] PTD/CPP Peptide-Mediated Delivery of siRNAs
    Presente, Asaf
    Dowdy, Steven F.
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (16) : 2943 - 2947
  • [5] Dual peptide-mediated targeted delivery of bioactive siRNAs to oral cancer cells in vivo
    Alexander-Bryant, Angela A.
    Zhang, Haiwen
    Attaway, Christopher C.
    Pugh, William
    Eggart, Laurence
    Sansevere, Robert M.
    Andino, Lourdes M.
    Lu Dinh
    Cantini, Liliana P.
    Jakymiw, Andrew
    ORAL ONCOLOGY, 2017, 72 : 123 - 131
  • [6] Dual peptide-mediated targeted delivery of siRNAs for the treatment of oral cancer
    Alexander-Bryant, Angela A.
    Zhang, Haiwen
    Pugh, William
    Dinh, Lu
    Attaway, Christopher
    Eggart, Laurence
    Sansevere, Robert
    Cantini, Liliana
    Jakymiw, Andrew
    CANCER RESEARCH, 2016, 76
  • [7] Fusogenic peptide delivery of bioactive siRNAs targeting CSNK2A1 for treatment of ovarian cancer
    Samec, Timothy
    Alatise, Kharimat Lora
    Boulos, Jessica
    Gilmore, Serena
    Hazelton, Anthony
    Alexander-Bryant, Angela
    MOLECULAR THERAPY NUCLEIC ACIDS, 2022, 30 : 95 - 111
  • [8] Peptide-mediated delivery of siRNAs targeting CSNK2A1 decreases migration of ovarian cancer cells in vitro.
    Hazelton, Anthony
    Samec, Timothy
    Boulos, Jessica
    Gilmore, Serena
    Alexander-Bryant, Angela
    CANCER RESEARCH, 2021, 81 (13)
  • [9] Structural requirements for non-covalent peptide-mediated cellular delivery of siRNAs
    Deshayes, Sebastien
    Van Mau, Nicole
    Morris, May C.
    Divita, Gilles
    Heitz, Frederic
    PEPTIDE REVOLUTION: GENOMICS, PROTEOMICS & THERAPEUTICS, 2004, : 802 - 804
  • [10] Structural requirements for non-covalent peptide-mediated cellular delivery of siRNAs
    Deshayes, S
    Van Mau, N
    Divita, G
    Heitz, F
    BIOPOLYMERS, 2003, 71 (03) : 409 - 409
1234